Prognostic Factors for Survival in Transverse Colon Cancers

Kucukarda A., Gokyer A., Sayin S., Gokmen I., Ozcan E., Kostek O., ...More

JOURNAL OF GASTROINTESTINAL CANCER, vol.53, no.1, pp.31-40, 2022 (ESCI, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 53 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.1007/s12029-021-00675-1
  • Journal Name: JOURNAL OF GASTROINTESTINAL CANCER
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.31-40
  • Keywords: Transverse colon cancer, Prognosis, Survival, BRAF V600E, Pathological stage, COLORECTAL-CANCER, MICROSATELLITE-INSTABILITY, ADJUVANT CHEMOTHERAPY, PROXIMAL COLON, STAGE-II, FLUOROURACIL, MUTATION
  • Marmara University Affiliated: Yes

Abstract

Background Transverse colon cancer (TCC) is a rare condition that accounts for 10% of all colon cancers. TCC was accepted more likely right-sided colon cancers. We aimed to investigate whether TCC differs from other colon tumors by using clinical, pathological, and molecular prognostic factors known to be important in colon cancer and if it differs in its own anatomical structure.